Anti‐Müllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 4-Reference-Cited by-同舟云学术

Anti‐Müllerian hormone and antral follicle count differ in their ability to predict cumulative treatment outcomes of the first complete ovarian stimulation cycle in patients from POSEIDON groups 3 and 4

Published:2020-07-19 Issue:9 Volume:46 Page:1801-1808
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Liu Luxin¹²^ORCID,Zhou Canquan¹²

Affiliation:

1. Reproductive Medicine CenterThe First Affiliated Hospital, Sun Yat‐Sen University Guangzhou China

2. Guangdong Provincial Key Laboratory of Reproductive MedicineThe First Affiliated Hospital, Sun Yat‐Sen University Guangzhou China

Funder

National Basic Research Program of China

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.14269

Reference27 articles.

1. Individualized controlled ovarian stimulation in expected poor-responders: an update

2. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

3. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept

4. The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome

5. Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prise en charge de première intention du couple infertile : mise à jour des RPC 2010 du CNGOF;Gynécologie Obstétrique Fertilité & Sénologie ;2024-05

2. Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception;Seminars in Reproductive Medicine;2024-03

3. Research Progress on Influencing Factors of IVF/ICSI Pregnancy Outcomes and Assisted Reproductive Strategies in Women with Low Ovarian Response according to the Standard of Poseidon Criteria;Advances in Clinical Medicine;2024

4. Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis;Human Reproduction;2023-07-20

5. SERUM ANTI – MULLERIAN HORMONE IN AZOOSPERMIA APPROACH;FARMACIA;2023-04-27